PT2651915T - Composto aricíclico contínuo - Google Patents
Composto aricíclico contínuoInfo
- Publication number
- PT2651915T PT2651915T PT118479807T PT11847980T PT2651915T PT 2651915 T PT2651915 T PT 2651915T PT 118479807 T PT118479807 T PT 118479807T PT 11847980 T PT11847980 T PT 11847980T PT 2651915 T PT2651915 T PT 2651915T
- Authority
- PT
- Portugal
- Prior art keywords
- arycyclic compound
- continuous arycyclic
- continuous
- compound
- arycyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201061424365P | 2010-12-17 | 2010-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2651915T true PT2651915T (pt) | 2016-07-14 |
Family
ID=46244825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT118479807T PT2651915T (pt) | 2010-12-17 | 2011-12-16 | Composto aricíclico contínuo |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9302996B2 (pt) |
| EP (1) | EP2651915B1 (pt) |
| JP (1) | JP5629380B2 (pt) |
| KR (1) | KR101530141B1 (pt) |
| CN (1) | CN103261185B (pt) |
| AU (1) | AU2011342039B2 (pt) |
| BR (1) | BR112013014966B1 (pt) |
| CA (1) | CA2821900C (pt) |
| DK (1) | DK2651915T3 (pt) |
| ES (1) | ES2586385T3 (pt) |
| HK (1) | HK1188597A1 (pt) |
| HU (1) | HUE029002T2 (pt) |
| MX (1) | MX347054B (pt) |
| PL (1) | PL2651915T3 (pt) |
| PT (1) | PT2651915T (pt) |
| RU (1) | RU2538964C1 (pt) |
| TW (1) | TWI537257B (pt) |
| WO (1) | WO2012081736A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2862856B1 (en) * | 2012-06-15 | 2018-08-01 | Mitsubishi Tanabe Pharma Corporation | Imidazole and triazole compounds as dgat-1 inhibitors |
| JP5721032B2 (ja) * | 2012-06-15 | 2015-05-20 | 田辺三菱製薬株式会社 | 医薬組成物 |
| DK3013796T3 (da) * | 2013-06-27 | 2020-03-16 | Lg Chemical Ltd | Biarylderivater som gpr120-agonister |
| US9988374B2 (en) | 2014-08-11 | 2018-06-05 | Angion Biomedica Corp. | Cytochrome P450 inhibitors and uses thereof |
| SG11201702115SA (en) * | 2014-09-17 | 2017-04-27 | Prevacus Inc | Synthesis of ent-progesterone and intermediates thereof |
| MY189770A (en) * | 2014-12-24 | 2022-03-04 | Lg Chemical Ltd | Biaryl derivative as gpr120 agonists |
| JP2018501279A (ja) | 2014-12-31 | 2018-01-18 | アンギオン バイオメディカ コーポレイション | 疾患を治療するための方法及び薬剤 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE204262T1 (de) | 1991-09-18 | 2001-09-15 | Glaxo Group Ltd | Benzanilidderivate als 5-ht1d-antagonisten |
| RU2109736C1 (ru) | 1992-12-17 | 1998-04-27 | Санкио Компани Лимитед | Производные бифенила и способ их получения |
| FI935373A0 (fi) | 1993-12-01 | 1993-12-01 | Iws International Inc | Kopplingsstycke eller koppling foer ledning |
| WO1999058518A2 (en) | 1998-05-12 | 1999-11-18 | American Home Products Corporation | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
| AU2935200A (en) | 1999-04-30 | 2000-11-17 | Pfizer Products Inc. | Compounds for the treatment of obesity |
| GB2351081A (en) | 1999-06-18 | 2000-12-20 | Lilly Forschung Gmbh | Pharmaceutically active imidazoline compounds and analogues thereof |
| US20030114457A1 (en) | 2001-07-09 | 2003-06-19 | Axys Pharmaceuticals, Inc. | 2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors |
| JP3600832B2 (ja) | 2002-01-28 | 2004-12-15 | 株式会社富士薬品 | 新規１，２，４−トリアゾール系化合物 |
| GB0209891D0 (en) | 2002-04-30 | 2002-06-05 | Glaxo Group Ltd | Novel compounds |
| CA2523714A1 (en) | 2003-04-30 | 2004-11-18 | The Institutes For Pharmaceutical Discovery, Llc | Substituted carboxylic acids |
| AR044152A1 (es) * | 2003-05-09 | 2005-08-24 | Bayer Corp | Derivados de alquilarilo, metodo de preparacion y uso para el tratamiento de la obesidad |
| MX2007003325A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores estearoil-coa-desaturasa. |
| CN101583352A (zh) * | 2005-07-29 | 2009-11-18 | 拜尔健康护理有限责任公司 | 治疗肥胖症的联苯氨基酸衍生物的制备和用途 |
| NZ597247A (en) | 2006-11-29 | 2013-06-28 | Abbott Lab | Inhibitors of diacylglycerol O-acylotransferase type 1 enzyme |
| JP2008255024A (ja) | 2007-04-02 | 2008-10-23 | Banyu Pharmaceut Co Ltd | ビアリールアミン誘導体 |
| WO2009011285A1 (ja) | 2007-07-13 | 2009-01-22 | Taisho Pharmaceutical Co., Ltd. | ヘテロアリールベンゼン化合物 |
| WO2009079593A1 (en) | 2007-12-17 | 2009-06-25 | Janssen Pharmaceutica N.V. | Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| US8394823B2 (en) | 2008-04-11 | 2013-03-12 | Bristol-Myers Squibb Company | Triazolopyridine compounds useful as DGAT1 inhibitors |
| CA2755253A1 (en) | 2009-03-18 | 2010-09-23 | Schering Corporation | Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| WO2011002067A1 (ja) | 2009-07-02 | 2011-01-06 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| WO2012009217A1 (en) | 2010-07-13 | 2012-01-19 | Merck Sharp & Dohme Corp. | Spirocyclic compounds |
| AU2011282989A1 (en) | 2010-07-28 | 2013-01-10 | Merck Sharp & Dohme Corp. | Imidazole derivatives |
| WO2012044567A2 (en) | 2010-09-30 | 2012-04-05 | Merck Sharp & Dohme Corp. | Imidazole derivatives |
| WO2012047772A2 (en) | 2010-10-07 | 2012-04-12 | Schering Corporation | Imidazole derivatives |
-
2011
- 2011-12-16 ES ES11847980.7T patent/ES2586385T3/es active Active
- 2011-12-16 AU AU2011342039A patent/AU2011342039B2/en not_active Ceased
- 2011-12-16 EP EP11847980.7A patent/EP2651915B1/en active Active
- 2011-12-16 BR BR112013014966-3A patent/BR112013014966B1/pt active IP Right Grant
- 2011-12-16 WO PCT/JP2011/079958 patent/WO2012081736A1/en active Application Filing
- 2011-12-16 KR KR1020137018647A patent/KR101530141B1/ko active IP Right Grant
- 2011-12-16 US US13/994,543 patent/US9302996B2/en not_active Expired - Fee Related
- 2011-12-16 CN CN201180060856.2A patent/CN103261185B/zh active Active
- 2011-12-16 RU RU2013132961/04A patent/RU2538964C1/ru active
- 2011-12-16 PT PT118479807T patent/PT2651915T/pt unknown
- 2011-12-16 MX MX2013006874A patent/MX347054B/es active IP Right Grant
- 2011-12-16 TW TW100146748A patent/TWI537257B/zh not_active IP Right Cessation
- 2011-12-16 CA CA2821900A patent/CA2821900C/en active Active
- 2011-12-16 JP JP2013526669A patent/JP5629380B2/ja not_active Expired - Fee Related
- 2011-12-16 DK DK11847980.7T patent/DK2651915T3/en active
- 2011-12-16 PL PL11847980.7T patent/PL2651915T3/pl unknown
- 2011-12-16 HU HUE11847980A patent/HUE029002T2/en unknown
-
2014
- 2014-02-20 HK HK14101634.4A patent/HK1188597A1/xx unknown
-
2016
- 2016-02-22 US US15/050,154 patent/US9975871B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20130261128A1 (en) | 2013-10-03 |
| EP2651915A4 (en) | 2014-05-28 |
| BR112013014966B1 (pt) | 2020-02-18 |
| RU2538964C1 (ru) | 2015-01-10 |
| MX2013006874A (es) | 2013-07-05 |
| US9975871B2 (en) | 2018-05-22 |
| HK1188597A1 (en) | 2014-05-09 |
| CN103261185A (zh) | 2013-08-21 |
| ES2586385T3 (es) | 2016-10-14 |
| US20160272614A1 (en) | 2016-09-22 |
| WO2012081736A1 (en) | 2012-06-21 |
| CA2821900C (en) | 2015-12-08 |
| HUE029002T2 (en) | 2017-01-30 |
| CA2821900A1 (en) | 2012-06-21 |
| AU2011342039B2 (en) | 2015-06-11 |
| US9302996B2 (en) | 2016-04-05 |
| PL2651915T3 (pl) | 2016-11-30 |
| TWI537257B (zh) | 2016-06-11 |
| BR112013014966A2 (pt) | 2016-09-13 |
| KR101530141B1 (ko) | 2015-06-18 |
| CN103261185B (zh) | 2014-12-10 |
| MX347054B (es) | 2017-04-07 |
| JP2013545719A (ja) | 2013-12-26 |
| DK2651915T3 (en) | 2016-07-18 |
| KR20130106422A (ko) | 2013-09-27 |
| EP2651915B1 (en) | 2016-05-25 |
| RU2013132961A (ru) | 2015-01-27 |
| TW201305126A (zh) | 2013-02-01 |
| EP2651915A1 (en) | 2013-10-23 |
| JP5629380B2 (ja) | 2014-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL223783A0 (en) | Pro-neurogenic compounds | |
| GB201015949D0 (en) | Compounds | |
| GB201008134D0 (en) | Compounds | |
| HK1187908A1 (zh) | 咪唑並三嗪酮化合物 | |
| AP2012006641A0 (en) | New compounds | |
| EP2605658A4 (en) | SPIROXAZOLIDINONVERBINDUNGEN | |
| GB201007347D0 (en) | Compounds | |
| EP2649050A4 (en) | LINKS | |
| HK1188597A1 (en) | Continuous arycyclic compound | |
| GB201002563D0 (en) | Compounds | |
| GB201008209D0 (en) | Compounds | |
| GB201001688D0 (en) | Compounds | |
| GB201002911D0 (en) | Compound | |
| GB201017315D0 (en) | Compound | |
| GB201007789D0 (en) | Novel Compound | |
| GB201002216D0 (en) | Compounds | |
| GB201015537D0 (en) | Compounds | |
| GB201008210D0 (en) | Compounds | |
| GB201001796D0 (en) | Compounds | |
| GB201007209D0 (en) | Compound | |
| GB201021494D0 (en) | Compounds | |
| GB201021228D0 (en) | Compound | |
| GB201015798D0 (en) | Compound | |
| GB201008820D0 (en) | Compound | |
| GB201005980D0 (en) | Compound |